Logo image
Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals
Journal article   Open access   Peer reviewed

Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals

Jeffrey M Jacobson, Julie K Jadlowsky, Simon F Lacey, Joseph A Fraietta, Gabriela Plesa, Hideto Chono, Dong H Lee, Irina Kulikovskaya, Chelsie Bartoszek, Fang Chen, …
Molecular therapy, v 29(2), pp 626-635
03 Feb 2021
PMID: 33186691
url
https://doi.org/10.1016/j.ymthe.2020.11.007View
Published, Version of Record (VoR)CC BY-NC-ND V4.0 Open

Abstract

CD4 Lymphocyte Count CD4-Positive T-Lymphocytes - immunology CD4-Positive T-Lymphocytes - metabolism DNA-Binding Proteins - genetics DNA-Binding Proteins - metabolism Endoribonucleases - genetics Endoribonucleases - metabolism Escherichia coli Proteins - genetics Escherichia coli Proteins - metabolism Genetic Therapy HIV Infections - immunology HIV Infections - metabolism HIV Infections - therapy HIV Infections - virology HIV-1 - physiology tat Gene Products, Human Immunodeficiency Virus - metabolism Viral Load Virus Replication
MazF is an Escherichia coli-derived endoribonuclease that selectively cleaves ACA sequences of mRNA prevalent in HIV. We administered a single infusion of autologous CD4 T lymphocytes modified to express a Tat-dependent MazF transgene to 10 HIV-infected individuals (six remaining on antiretroviral therapy [ART]; four undergoing treatment interruption post-infusion) in order to provide a population of HIV-resistant immune cells. In participants who remained on ART, increases in CD4 and CD8 T cell counts of ~200 cells/mm each occurred within 2 weeks of infusion and persisted for at least 6 months. Modified cells were detectable for several months in the blood and trafficked to gastrointestinal lymph tissue. HIV-1 Tat introduced ex vivo to the modified CD4 T cells induced MazF expression in both pre- and post-infusion samples, and MazF expression was detected in vivo post-viral-rebound during ATI. One participant experienced mild cytokine release syndrome. In sum, this study of a single infusion of MazF-modified CD4 T lymphocytes demonstrated safety of these cells, distribution to lymph tissue and maintenance of Tat-inducible MazF endoribonuclease activity, as well as sustained elevation of blood CD4 and CD8 T cell counts. Future studies to assess effects on viremia and latent proviral reservoir are warranted.

Metrics

13 Record Views
5 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Web of Science research areas
Biotechnology & Applied Microbiology
Genetics & Heredity
Medicine, Research & Experimental
Logo image